Device
Neurovision
Neurovision is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Ph not_applicable
1
33%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (66.7%)
N/A1 (33.3%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia
NCT00348127
completedphase_1
Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia
NCT00348218
completednot_applicable
A Singapore Study to Assess How Neurovision Improve the Vision of Adults With Low to Moderate Myopia
NCT00348075
Clinical Trials (3)
Showing 3 of 3 trials
NCT00348127Phase 1
A Singapore Pilot Study to Assess Neurovision in Treatment of Low Myopia
NCT00348218Phase 1
Pilot Study of Neurovision to Improve Vision and Slow Myopia Progression in Children With Myopia
NCT00348075Not Applicable
A Singapore Study to Assess How Neurovision Improve the Vision of Adults With Low to Moderate Myopia
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3